XML 65 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Further Detail of Profit or Loss
12 Months Ended
Dec. 31, 2019
Further Detail of Profit or Loss [Abstract]  
Further detail of profit or loss

Note 14Further detail of profit or loss

   For the year ended December 31 
   2017   2018   2019 
   Thousands USD   Thousands USD   Thousands USD 
A. Research and development expenses, net            
Payroll   7,419    4,890    4,834 
Materials   1,844    1,065    1,001 
Subcontractors   151    70    82 
Patent registration   57    70    144 
Depreciation   442    880    1,534 
Rental fees and maintenance   824    908    197 
Other   244    782    339 
    10,981    8,665    8,131 
Less – government grants   (162)   (42)   (49)
    10,819    8,623    8,082 
B. Sales and marketing expenses               
Payroll   1,497    2,226    2,873 
Marketing, advertising and commissions   383    1,381    1,808 
Rental fees and maintenance   59    64    114 
Travel abroad   234    201    317 
Depreciation   10    186    212 
Other   -    201    145 
    2,183    4,259    5,469 
                
C. General and administrative expenses               
Payroll   762    996    1,000 
Fees   68    32    22 
Professional services   1,460    1,114    1,358 
Directors pay   493    306    214 
Office expenses   282    311    359 
Travel abroad   86    45    37 
Depreciation   -    -    78 
Rental fees and maintenance   84    91    43 
Other   128    107    159 
    3,363    3,002    3,270 
D. Finance income               
Revaluation of liability in respect of government grants   102    -    58 
Revaluation of financial liabilities at fair value through profit or loss (**)   -    -    8,707 
Bank interest and fees   -    54    - 
    102    54    8,765 
Finance expense               
Exchange rate differences   889    127    151 
Bank fees   28    -    14 
Finance expense in respect of lease liability (*)   -    -    425 
Fundraising expenses   -    -    1,693 
Revaluation of liability in respect of government grants   -    265    - 
    917    392    2,283 

  

(*) See Note 2.C regarding initial application of IFRS 16.
(**) See Note 11.B regarding financing transactions resulted in issuance of financial instruments.